Study Findings from Peking Union Medical College Hospital Update Knowledge in Breast Cancer (Preclinical evaluation of the theranostic potential of 89Zr/177Lu-labeled anti-TROP-2 antibody in triple-negative breast cancer model).
In: Women's Health Weekly, 2024-02-02, S. 1121-1121
serialPeriodical
Zugriff:
A study conducted at Peking Union Medical College Hospital focused on triple-negative breast cancer (TNBC), a highly aggressive form of breast cancer. The researchers aimed to develop a radiolabeled antibody, NY003, that could be used for imaging and therapy in TNBC. The study found that NY003 specifically accumulated in TNBC tumors and effectively suppressed tumor growth in a mouse model. The researchers concluded that NY003 has potential as a theranostic agent for TNBC. [Extracted from the article]
Copyright of Women's Health Weekly is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Study Findings from Peking Union Medical College Hospital Update Knowledge in Breast Cancer (Preclinical evaluation of the theranostic potential of 89Zr/177Lu-labeled anti-TROP-2 antibody in triple-negative breast cancer model).
|
---|---|
Zeitschrift: | Women's Health Weekly, 2024-02-02, S. 1121-1121 |
Veröffentlichung: | 2024 |
Medientyp: | serialPeriodical |
ISSN: | 1078-7240 (print) |
Schlagwort: |
|
Sonstiges: |
|